HistoWiz is a series c plus startup based in United States. 1 investor tracked.
Based in the United States, HistoWiz is a startup founded in 2017. Its most recent tracked round is Series A. Brouky records 3 investors associated with the company.
HistoWiz automates histopathology with rapid turnaround time for researchers in academia, biotech and pharma. The company processes tissue specimens and digitizes the results, hosting client's data on a proprietary platform, PathologyMap.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.